To include your compound in the COVID-19 Resource Center, submit it here.

GSK closing neuroscience R&D center in Shanghai

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said it plans to close its Neuroscience R&D Center in Shanghai "following a portfolio review

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE